DRG International, Inc. Hepcidin 25 (Bioactive) HS Presented at Ash Annual Meeting 2015
Springfield, New Jersey, USA (December 2015) — DRG International, Inc. was proud to be a featured participant at ASH 2015, held in Orlando, FL from December 5 – 7, 2015!
DRG Will Exhibit at Arab Health 2016!
We are pleased to announce that the DRG Group will exhibit at the largest healthcare exhibition & congress in the Middle East: ARAB HEALTH.
Unique Assay For DRG:HYBRID-XL®: Hepcidin 25 (Bioactive)
DRG is proud to announce that Hepcidin 25 (bioactive) is now available for DRG:HYBRiD-XL.
Two New Assays For DRG:HYBRID-XL®
DRG is expanding the Fertility panel with LH and Prolactin! DRG is proud to launch two parameters: LH and Prolactin are now available for our lab analyzer DRG:HYBRiD-XL®.
DRG Products On Display in Vietnam!
DRG products were on display in Vietnam at the HCM Medical University Biochemistry Congress on Tuesday, March 1, 2016!
DRG Will Exhibit at Medlab Asia Pacific 2016!
We are pleased to announce that the DRG Group will exhibit at MEDLAB Asia Pacific 2016. The show will take place in Singapore at The Sands Expo and Convention Centre, from March 22 – 24, 2016.
DRG Successful Exhibit and Training at Arab Health 2016!
The DRG Group recently exhibited at the largest healthcare exhibition & congress in the Middle East: ARAB HEALTH from January 25 – 28, 2016 with great success!
Martina Werner, Member of the European Parliament, Visited the District of Marburg-Biedenkopf
Together with Sören Bartol of Marburg-Biedenkopf, Member of the Federal Parliament, and the District Administrator Kirsten Fründt, she toured various companies in the county.
Cystatin C: New Clinical Chemistry Parameter Available For DRG:HYBRiD-XL
DRG is glad to announce the next release of a clinical chemistry assay. Cystatin C is the latest released parameter for DRG:HYBRiD-XL and is ready to be purchased!
Martina Werner, Member of the European Parliament Visits Marburg-Biedenkopf District and DRG International
Martina Werner, Member of the European Parliament, visited the district of Marburg-Biedenkopf on Friday, January 23, 2016.
Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.
Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.